51. Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity.
- Author
-
Clayton GM, Wang Y, Crawford F, Novikov A, Wimberly BT, Kieft JS, Falta MT, Bowerman NA, Marrack P, Fontenot AP, Dai S, and Kappler JW
- Subjects
- Crystallography, X-Ray, HLA-DP beta-Chains chemistry, Humans, Lung pathology, Models, Molecular, Sodium chemistry, Sodium metabolism, Autoimmunity, Berylliosis immunology, Beryllium metabolism, CD4-Positive T-Lymphocytes metabolism, HLA-DP beta-Chains metabolism, Hypersensitivity immunology, Receptors, Antigen, T-Cell metabolism
- Abstract
T-cell-mediated hypersensitivity to metal cations is common in humans. How the T cell antigen receptor (TCR) recognizes these cations bound to a major histocompatibility complex (MHC) protein and self-peptide is unknown. Individuals carrying the MHCII allele, HLA-DP2, are at risk for chronic beryllium disease (CBD), a debilitating inflammatory lung condition caused by the reaction of CD4 T cells to inhaled beryllium. Here, we show that the T cell ligand is created when a Be(2+) cation becomes buried in an HLA-DP2/peptide complex, where it is coordinated by both MHC and peptide acidic amino acids. Surprisingly, the TCR does not interact with the Be(2+) itself, but rather with surface changes induced by the firmly bound Be(2+) and an accompanying Na(+) cation. Thus, CBD, by creating a new antigen by indirectly modifying the structure of preexisting self MHC-peptide complex, lies on the border between allergic hypersensitivity and autoimmunity., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF